Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology

Long-Term Monitoring and Disease Progression

At a Glance

NEDSGO can change over time in some children, affecting development, movement, brain structure, jaw growth, and breathing. Regular, symptom-based follow-up with neurology, dental, developmental, and airway specialists helps identify changes early and guide support.

Because NEDSGO is an ultra-rare condition, doctors are still learning about its long-term path. While many genetic conditions remain stable, current research suggests that NEDSGO can be progressive for some children [1][2]. This means that symptoms may change or new challenges may appear as your child grows. Understanding what to monitor—and why—is the best way to ensure your child receives the right support at the right time.

Understanding Progression

In NEDSGO, progression can happen in two main areas: neurological function and craniofacial (head and face) structure.

  • Neurological Changes: Some children experience developmental regression, which is a loss of previously learned cognitive or social skills [1]. This may be accompanied by new movement issues, such as limb tremors (shaking) or gait ataxia (unsteadiness while walking) [2].
  • Brain Atrophy: Follow-up imaging has shown atrophy (shrinking) of the cerebrum (the largest part of the brain) or the cerebellum (the part that controls balance) in some cases [1][3]. While it is not yet known exactly when this starts or how fast it moves, monitoring these changes helps neurologists adjust therapies [3].
  • Craniofacial Growth: The growth of the jawbones (specifically maxillary hypertrophy or enlargement of the upper jaw) can also continue over time [2][3]. In rare, severe reported cases, significant bone growth at the base of the skull caused brainstem compression, where the bone pressed on the part of the brain that controls vital functions like breathing and heart rate [2].

A Practical Monitoring Plan

Since there are no universal guidelines, your care team will likely create a phenotype-driven plan based on your child’s specific symptoms [3].

Specialist What They Monitor Common Tools/Tests
Neurologist Seizure control, motor skills, and brain structure. Clinical visits, symptom-driven EEGs, and Brain MRIs as needed.
Craniofacial/Dentist Gum overgrowth, jawbone changes, and tooth eruption. Dental exams, photos, and symptom-driven CT scans.
Developmental Team Cognitive milestones, speech, and adaptive skills. Standardized developmental and neuropsychological testing.
ENT / Airway Nasal patency (openness) and sleep-disordered breathing. Sleep studies (polysomnography) if snoring or gasping occurs.

When to Request a Clinical Evaluation or New Imaging

While your doctors will set a routine schedule for clinical visits, certain “triggers” should prompt an earlier evaluation (keeping in mind that imaging like CT and MRI require weighing the risks of radiation and sedation):

  • Skill Loss: Any noticeable loss or “plateau” in language, motor skills, or feeding [4].
  • New Physical Signs: Development of a new tremor, frequent headaches, vomiting, or a change in how your child moves their eyes (nystagmus) [5][2].
  • Breathing Changes: New snoring, gasping for air at night, or a change in voice quality [6][7].

Managing “Scan Anxiety”

Living with an ultra-rare, progressive diagnosis carries a heavy psychological weight. Parents often experience “scan anxiety”—a period of intense stress and hypervigilance leading up to and following routine medical tests [8].

It is important to remember that these clinical evaluations are tools for empowerment, not just for “bad news.” They allow your care team to intervene early—for example, by adjusting seizure medications or planning a dental procedure—before a symptom becomes a crisis [9]. Validating your fear and seeking support from rare-disease communities can help you manage the emotional demands of long-term monitoring [10]. You are the expert on your child; your daily observations are often just as valuable to the medical team as the scans themselves [11].

Common questions in this guide

What signs might show that NEDSGO is progressing?
Possible changes include loss or plateau of developmental skills, new tremors, unsteady walking, headaches, vomiting, or involuntary eye movements. Families should also watch for worsening jaw or gum growth, snoring, gasping during sleep, swallowing changes, or a voice change, and report new or worsening symptoms to the care team.
How is a child with NEDSGO monitored over time?
Monitoring is individualized and may include visits with a neurologist, dental or craniofacial specialist, developmental team, and ENT or airway specialist. Depending on symptoms, clinicians may use developmental testing, EEG, brain MRI, dental exams or CT, and sleep studies.
When should my child have another MRI or CT scan for NEDSGO?
New skill loss, a developmental plateau, movement changes, headaches, vomiting, involuntary eye movements, breathing problems, or concerning facial growth may prompt the team to consider imaging. The care team weighs the possible benefit against CT radiation and the risks of sedation, especially in children.
Can NEDSGO affect brain structure or cause pressure on the brainstem?
Some children have changes such as shrinkage of the cerebrum or cerebellum on follow-up imaging. In rare severe cases, bone growth at the base of the skull can press on the brainstem, which helps control breathing and heart rate; this is not expected in every child.
What does developmental regression mean in NEDSGO?
Developmental regression means losing skills a child previously learned, such as language, movement, social abilities, or feeding skills. Any noticeable loss or plateau should be shared promptly with the child's clinician so the team can decide whether an evaluation is needed.
How can parents manage anxiety about repeated NEDSGO testing?
Keep a simple record of developmental milestones, movements, sleep, breathing, and other changes to share at visits. Ask the care team about the purpose and timing of each test, and seek support from family, clinicians, or rare-disease communities when scan anxiety becomes overwhelming.

Get notified when new evidence is published on neurodevelopmental disorder with seizures and gingival overgrowth.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth.

    Harms FL, Rexach JE, Efthymiou S, et al.

    European journal of human genetics : EJHG 2024; (32(5)):558-566 doi:10.1038/s41431-024-01563-5.

    PMID: 38374468
  2. 2

    Biallelic frameshift variant in the TBC1D2B gene in two siblings with progressive gingival overgrowth, fibrous dysplasia of face, and mental deterioration.

    Correia-Costa GR, de Leeuw N, Pfundt R, et al.

    Clinical genetics 2022; (102(6)):537-542 doi:10.1111/cge.14215.

    PMID: 36029130
  3. 3

    A Novel Homozygous TBC1D2B Variant Disrupts Functional Domains and Suggests Impaired Rab-GTPase Regulation in Neurodevelopmental Disorder.

    Ozturk M, Arslan CB, Akbulut E, et al.

    Developmental neurobiology 2025; (85(4)):e22998 doi:10.1002/dneu.22998.

    PMID: 40898781
  4. 4

    Developmental and/or Epileptic Encephalopathy with Spike-Wave Activation in Sleep: From Thalamocortical Mechanisms to Precision Therapy.

    Samanta D

    Children (Basel, Switzerland) 2026; (13(8)) doi:10.3390/children13080993.

    PMID: 42650333
  5. 5

    Ventral Decompression in Chiari Malformation, Basilar Invagination, and Related Disorders.

    Ridder T, Anderson RC, Hankinson TC

    Neurosurgery clinics of North America 2015; (26(4)):571-8.

    PMID: 26408067
  6. 6

    Fibrous Dysplasia of the Ethmoid Bone Diagnosed in a 10-Year-Old Patient.

    Resler Z, Morawska-Kochman M, Resler K, Zatoński T

    Medicina (Kaunas, Lithuania) 2024; (61(1)) doi:10.3390/medicina61010045.

    PMID: 39859027
  7. 7

    Coronavirus disease 2019-associated persistent cough and Chiari malformation type I resulting in acute respiratory failure: illustrative case.

    Piscopo AJ, Teferi N, Marincovich A, et al.

    Journal of neurosurgery. Case lessons 2023; (6(25)).

    PMID: 38109716
  8. 8

    Using Interpretative Phenomenological Analysis to Explore the Experiences of Mothers Who Have a Child With the Rare Genetic Disorder, HNRNPU-Related Neurodevelopmental Disorder: "Some Days, I Wear a Cape and I'm Super Mom and Some Days, I Have to Hide Under My Cape and I Can't Get Out for a Few Days".

    Overton I, Docherty F, Balasubramanian M

    Journal of genetic counseling 2026; (35(5)).

    PMID: 42922377
  9. 9

    Beyond seizures: the hidden burden of developmental epileptic encephalopathies.

    Dell'Isola GB, Sorrentino M, Massara S, et al.

    Frontiers in neurology 2026; (17()):1960314 doi:10.3389/fneur.2026.1960314.

    PMID: 42953089
  10. 10

    The mental health and traumatic experiences of mothers of children with 22q11DS.

    Finless A, Rideout AL, Xiong T, et al.

    European journal of psychotraumatology 2024; (15(1)):2353532 doi:10.1080/20008066.2024.2353532.

    PMID: 38780146
  11. 11

    Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.

    Millichap JJ, Harden CL, Dlugos DJ, et al.

    Epilepsia open 2021; (6(1)):38-44 doi:10.1002/epi4.12466.

    PMID: 33681646

This page explains long-term monitoring and disease progression in NEDSGO for informational purposes only and does not constitute medical advice. Your child's care team should guide decisions about evaluations, imaging, sedation, and treatment.